IntoCell, Inc. (KOSDAQ:287840)
South Korea
· Delayed Price · Currency is KRW 25,100
+1,200 (5.02%)
At close: Aug 13, 2025, 3:30 PM KST
IntoCell Revenue
IntoCell had revenue of 109.17M KRW in the quarter ending March 31, 2025, with 63.75% growth. This brings the company's revenue in the last twelve months to 2.95B, up 176.59% year-over-year. In the year 2024, IntoCell had annual revenue of 2.91B with 79.72% growth.
Revenue (ttm)
2.95B
Revenue Growth
+176.59%
P/S Ratio
130.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
386.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 15.69T |